selected publications
-
academic article
- Bailey, A., Harrington, C., & Evans, E. (2023). A scoping review of community-based post-opioid overdose intervention programs: implications of program structure and outcomes. Health & Justice, 11(3). https://doi.org/10.1186/s40352-022-00201-w
- Bailey, A., & Evans, E. (2023). Holyoke Early Access to Recovery and Treatment (HEART): A case study of a court-based intervention to reduce opioid overdose. Journal of Ethnicity in Substance Abuse https://doi.org/10.1080/15332640.2023.2172758
- Harrington, C., Bailey, A., Delorme, E., Hano, S., & Evans, E. (2023). “And Then COVID Hits”: A Qualitative Study of How Jails Adapted Services to Treat Opioid Use Disorder During COVID-19. Substance Use & Misuse https://doi.org/10.1080/10826084.2022.2155480
- Goodsmith, N., Cohen, A. N., Pedersen, E. R., Evans, E., Young, A. S., & Hamilton, A. B. (2023). Predictors of Functioning and Recovery Among Men and Women Veterans with Schizophrenia. Community Mental Health Journal, 59(1), 110-121. 10.1007/s10597-022-00979-x
- Geissler, K. H., Evans, E., Johnson, J. K., & Whitehill, J. M. (2022). A Scoping Review of Data Sources for the Conduct of Policy-Relevant Substance Use Research. Public Health Reports, 137(5), 944-954. 10.1177/00333549211038323
- Evans, E. (2022). Commentary on Adams et al .: using administrative big data for the public good. Addiction, 117(10), 2649-2650. 10.1111/add.15988
- Matsumoto, A., Santelices, C., Evans, E., Pivovarova, E., Stopka, T. J., Ferguson, W. J., & Friedmann, P. D. (2022). Jail-based reentry programming to support continued treatment with medications for opioid use disorder: Qualitative perspectives and experiences among jail staff in Massachusetts. International Journal of Drug Policy, 109, 103823. 10.1016/j.drugpo.2022.103823
- Pivovarova, E., Evans, E., Stopka, T. J., Santelices, C., Ferguson, W. J., & Friedmann, P. D. (2022). Legislatively mandated implementation of medications for opioid use disorders in jails: A qualitative study of clinical, correctional, and jail administrator perspectives. Drug and Alcohol Dependence, 234, 109394. 10.1016/j.drugalcdep.2022.109394
- Stopka, T. J., Rottapel, R. E., Ferguson, W. J., Pivovarova, E., Toro-Mejias, L. D., Friedmann, P. D., & Evans, E. (2022). Medication for opioid use disorder treatment continuity post-release from jail: A qualitative study with community-based treatment providers. International Journal of Drug Policy, 110, 103803. 10.1016/j.drugpo.2022.103803
- Evans, E., Wilson, D., & Friedmann, P. D. (2022). Recidivism and mortality after in-jail buprenorphine treatment for opioid use disorder. Drug and Alcohol Dependence, 231, 109254. 10.1016/j.drugalcdep.2021.109254
- Evans, E., Delorme, E., Cyr, K. D., & Geissler, K. H. (2022). The Massachusetts public health data warehouse and the opioid epidemic: A qualitative study of perceived strengths and limitations for advancing research. Preventive Medicine Reports, 28, 101847. 10.1016/j.pmedr.2022.101847
- Evans, E., Pivovarova, E., Stopka, T. J., Santelices, C., Ferguson, W. J., & Friedmann, P. D. (2022). Uncommon and preventable: Perceptions of diversion of medication for opioid use disorder in jail. Journal of Substance Abuse Treatment, 138, 108746. 10.1016/j.jsat.2022.108746
- Fiddian-Green, A., Gubrium, A., Harrington, C., & Evans, E. (2022). Women-Reported Barriers and Facilitators of Continued Engagement with Medications for Opioid Use Disorder. International Journal of Environmental Research and Public Health, 19(15), 9346. 10.3390/ijerph19159346
- Donelan, C., Hayes, E., Potee, R., Schwartz, L., & Evans, E. (2021). COVID-19 and treating incarcerated populations for opioid use disorder.. Journal of Substance Abuse Treatment, 124, 108216. 10.1016/j.jsat.2020.108216
- Hser, Y., Zhu, Y., Fei, Z., Mooney, L., Evans, E., Kelleghan, A., Matthews, A., Yoo, C., & Saxon, A. (2021). Long-term follow-up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial.. Addiction 10.1111/add.15594
- Hser, Y., Zhu, Y., Fei, Z., Mooney, L. J., Evans, E., Kelleghan, A., Matthews, A., Yoo, C., & Saxon, A. J. (2021). Long‐term follow‐up assessment of opioid use outcomes among individuals with comorbid mental disorders and opioid use disorder treated with buprenorphine or methadone in a randomized clinical trial. Addiction 10.1111/add.15594
- Evans, E., Stopka, T., Pivovarova, E., Murphy, S., Taxman, F., Ferguson, W., Bernson, D., Santelices, C., McCollister, K., Hoskinson R, J., Lincoln, T., Friedmann, P., & MassJCOIN Research, G. (2021). Massachusetts Justice Community Opioid Innovation Network (MassJCOIN).. Journal of Substance Abuse Treatment 10.1016/j.jsat.2021.108275
- Evans, E., Goldwater, E., Stanek, E. J., Brierley-Bowers, P., Buchanan, D., & Whitehill, J. M. (2021). Prevalence and Correlates of Cannabis Use in Massachusetts after Cannabis Legalization and before Retail Sales. Journal of Psychoactive Drugs, 53(2), 158-167. 10.1080/02791072.2020.1850945
- Zhu, Y., Mooney, L. J., Yoo, C., Evans, E., Kelleghan, A., Saxon, A. J., Curtis, M. E., & Hser, Y.-I. (2021). Psychiatric comorbidity and treatment outcomes in patients with opioid use disorder: Results from a multisite trial of buprenorphine-naloxone and methadone. Drug and Alcohol Dependence, 228, 108996. 10.1016/j.drugalcdep.2021.108996
- Evans, E., Delorme, E., Cyr, K., & Goldstein, D. M. (2020). A qualitative study of big data and the opioid epidemic: recommendations for data governance. BMC Medical Ethics, 21(1), 101. 10.1186/s12910-020-00544-9
- Geissler, K. H., & Evans, E. (2020). Changes in Medicaid Acceptance by Substance Abuse Treatment Facilities After Implementation of Federal Parity. Medical Care, 58(2), 101-107. 10.1097/mlr.0000000000001242
- Evans, E., Goff, S. L., Upchurch, D. M., & Grella, C. E. (2020). Childhood adversity and mental health comorbidity in men and women with opioid use disorders. Addictive Behaviors, 102, 106149. 10.1016/j.addbeh.2019.106149
- Friedmann, P., Abraham, A., Evans, E., Glass, J., Ilgen, M., & Montgomery, L. (2020). Editorial: COVID-19 and its impact on SUD treatment.. Journal of Substance Abuse Treatment, 117, 108091. 10.1016/j.jsat.2020.108091
- Montgomery, L., Friedmann, P., Abraham, A., Evans, E., Glass, J., & Ilgen, M. (2020). Editorial: Health equity in substance use disorder treatment.. Journal of Substance Abuse Treatment, 118, 108101. 10.1016/j.jsat.2020.108101
- Evans, E., Harrington, C., Roose, R., Lemere, S., & Buchanan, D. (2020). Perceived Benefits and Harms of Involuntary Civil Commitment for Opioid Use Disorder.. The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics, 48(4), 718-734. 10.1177/1073110520979382
- Evans, E., Zhu, Y., Yoo, C., Huang, D., & Hser, Y. (2019). Criminal justice outcomes over 5 years after randomization to buprenorphine‐naloxone or methadone treatment for opioid use disorder. Addiction, 114(8), 1396-1404. 10.1111/add.14620
- Evans, E., Yoo, C., Huang, D., Saxon, A. J., & Hser, Y.-I. (2019). Effects of access barriers and medication acceptability on buprenorphine-naloxone treatment utilization over 2 years: Results from a multisite randomized trial of adults with opioid use disorder. Journal of Substance Abuse Treatment, 106, 19-28. 10.1016/j.jsat.2019.08.002
- Evans, E., Tennenbaum, D. L., Washington, D. L., & Hamilton, A. B. (2019). Why Women Veterans Do Not Use VA-Provided Health and Social Services: Implications for Health Care Design and Delivery. Journal of Humanistic Psychology 10.1177/0022167819847328
- Zhu, Y., Evans, E., Mooney, L. J., Saxon, A. J., Kelleghan, A., Yoo, C., & Hser, Y.-I. (2018). Correlates of Long-Term Opioid Abstinence After Randomization to Methadone Versus Buprenorphine/Naloxone in a Multi-Site Trial. Journal of Neuroimmune Pharmacology, 13(4), 488-497. 10.1007/s11481-018-9801-x
- Krebs, E., Enns, B., Evans, E., Urada, D., Anglin, M. D., Rawson, R. A., Hser, Y.-I., & Nosyk, B. (2018). Cost-Effectiveness of Publicly Funded Treatment of Opioid Use Disorder in California. Annals of Internal Medicine, 168(1), 10. 10.7326/m17-0611
- Evans, E., Upchurch, D. M., Simpson, T., Hamilton, A. B., & Hoggatt, K. J. (2018). Differences by Veteran/civilian status and gender in associations between childhood adversity and alcohol and drug use disorders. Social Psychiatry and Psychiatric Epidemiology, 53(4), 421-435. 10.1007/s00127-017-1463-0
- Evans, E., Herman, P. M., Washington, D. L., Lorenz, K. A., Yuan, A., Upchurch, D. M., Marshall, N., Hamilton, A. B., Liu, L., Liu, S. L., Taylor, L., & Taylor, S. L. (2018). Gender Differences in Use of Complementary and Integrative Health by U.S. Military Veterans with Chronic Musculoskeletal Pain. Women's Health Issues, 28(5), 379-386. 10.1016/j.whi.2018.07.003
- Evans, E., Glover, D. L., Washington, D. L., & Hamilton, A. B. (2018). Psychosocial Factors that Shape Substance Abuse and Related Mental Health of Women Military Veterans who Use Community-Based Services. Substance Use & Misuse, 53(11), 1878-1892. 10.1080/10826084.2018.1441309
- Krebs, E., Min, J. E., Evans, E., Li, L., Liu, L., Huang, D., Urada, D., Kerr, T., Hser, Y.-I., & Nosyk, B. (2017). Estimating State Transitions for Opioid Use Disorders. Medical Decision Making, 37(5), 483-497. 10.1177/0272989x16683928
- Evans, E., Grella, C. E., Washington, D. L., & Upchurch, D. M. (2017). Gender and race/ethnic differences in the persistence of alcohol, drug, and poly-substance use disorders. Drug and Alcohol Dependence, 174, 128-136. 10.1016/j.drugalcdep.2017.01.021
- Evans, E., Grella, C. E., & Upchurch, D. M. (2017). Gender differences in the effects of childhood adversity on alcohol, drug, and polysubstance-related disorders. Social Psychiatry and Psychiatric Epidemiology, 52(7), 901-912. 10.1007/s00127-017-1355-3
- Wang, L., Min, J. E., Krebs, E., Evans, E., Huang, D., Liu, L., Hser, Y.-I., & Nosyk, B. (2017). Polydrug use and its association with drug treatment outcomes among primary heroin, methamphetamine, and cocaine users. International Journal of Drug Policy, 49, 32-40. 10.1016/j.drugpo.2017.07.009
- Krebs, E., Urada, D., Evans, E., Huang, D., Hser, Y.-I., & Nosyk, B. (2017). The costs of crime during and after publicly funded treatment for opioid use disorders: a population-level study for the state of California. Addiction, 112(5), 838-851. 10.1111/add.13729
- Hser, Y., Evans, E., Huang, D., Weiss, R., Saxon, A., Carroll, K. M., Woody, G., Liu, D., Wakim, P., Matthews, A. G., Hatch‐Maillette, M., Jelstrom, E., Wiest, K., McLaughlin, P., & Ling, W. (2016). Long‐term outcomes after randomization to buprenorphine/naloxone versus methadone in a multi‐site trial. Addiction, 111(4), 695-705. 10.1111/add.13238
- Nosyk, B., Li, L., Evans, E., Urada, D., Huang, D., Wood, E., Rawson, R., & Hser, Y.-I. (2015). Erratum to “Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, US: 1991–2012” [Drug Alcohol Depend. 143 (2014) 149–157]. Drug and Alcohol Dependence, 148, 230-232. 10.1016/j.drugalcdep.2014.10.018
- Evans, E., Kelleghan, A., Li, L., Min, J., Huang, D., Urada, D., Hser, Y., & Nosyk, B. (2015). Gender differences in mortality among treated opioid dependent patients. Drug and Alcohol Dependence, 155, 228-235. 10.1016/j.drugalcdep.2015.07.010
- Evans, E., Padwa, H., Li, L., Lin, V., & Hser, Y.-I. (2015). Heterogeneity of Mental Health Service Utilization and High Mental Health Service Use Among Women Eight Years After Initiating Substance Use Disorder Treatment. Journal of Substance Abuse Treatment, 59, 10-19. 10.1016/j.jsat.2015.06.021
- Hser, Y.-I., Evans, E., Grella, C., Ling, W., & Anglin, D. (2015). Long-Term Course of Opioid Addiction. Harvard Review of Psychiatry, 23(2), 76-89. 10.1097/hrp.0000000000000052
- Hser, Y.-I., Lanza, H. I., Li, L., Kahn, E., Evans, E., & Schulte, M. (2015). Maternal Mental Health and Children’s Internalizing and Externalizing Behaviors: Beyond Maternal Substance Use Disorders. Journal of Child and Family Studies, 24(3), 638-648. 10.1007/s10826-013-9874-3
- Evans, E., Li, L., Min, J., Huang, D., Urada, D., Liu, L., Liu, S. L., Taylor, L., Taylor, S. L., Hser, Y.-I., & Nosyk, B. (2015). Mortality among individuals accessing pharmacological treatment for opioid dependence in California, 2006-10. Addiction, 110(6), 996-1005. 10.1111/add.12863
- Schulte, M., Hser, Y., Saxon, A., Evans, E., Li, L., Huang, D., Hillhouse, M., Thomas, C., & Ling, W. (2015). Risk Factors Associated with HCV Among Opioid-Dependent Patients in a Multisite Study. Journal of Community Health, 40(5), 940-947. 10.1007/s10900-015-0016-2
- Nosyk, B., Min, J. E., Evans, E., Li, L., Liu, L., Lima, V. D., Wood, E., & Montaner, J. S. G. (2015). The Effects of Opioid Substitution Treatment and Highly Active Antiretroviral Therapy on the Cause-Specific Risk of Mortality Among HIV-Positive People Who Inject Drugs. Clinical Infectious Diseases, 61(7), 1157-1165. 10.1093/cid/civ476
- Nosyk, B., Li, L., Evans, E., Huang, D., Min, J., Kerr, T., Brecht, M., & Hser, Y. (2014). Characterizing longitudinal health state transitions among heroin, cocaine, and methamphetamine users. Drug and Alcohol Dependence, 140, 69-77. 10.1016/j.drugalcdep.2014.03.029
- Hser, Y.-I., Evans, E., Li, L., Metchik-Gaddis, A., & Messina, N. (2014). Children of treated substance-abusing mothers: A 10-year prospective study. Clinical Child Psychology and Psychiatry, 19(2), 217-232. 10.1177/1359104513486999
- Hser, Y.-I., Evans, E., & Grella, C. (2014). Commentary on Degenhardtet al. (2014): Regional variation in the global burden of disease attributable to opioid dependence-where do the data come from and does population size matter?. Addiction, 109(8), 1334-1335. 10.1111/add.12597
- Evans, E., Li, L., Urada, D., & Anglin, M. D. (2014). Comparative Effectiveness of California’s Proposition 36 and Drug Court Programs Before and After Propensity Score Matching. Crime & Delinquency, 60(6), 909-938. 10.1177/0011128710382342
- Evans, E., Li, L., Buoncristiani, S., & Hser, Y.-I. (2014). Perceived Neighborhood Safety, Recovery Capital, and Successful Outcomes Among Mothers 10 years After Substance Abuse Treatment. Substance Use & Misuse, 49(11), 1491-1503. 10.3109/10826084.2014.913631
- Nosyk, B., Li, L., Evans, E., Urada, D., Huang, D., Wood, E., Rawson, R., & Hser, Y.-I. (2014). Utilization and outcomes of detoxification and maintenance treatment for opioid dependence in publicly-funded facilities in California, USA: 1991–2012. Drug and Alcohol Dependence, 143, 149-157. 10.1016/j.drugalcdep.2014.07.020
- Prendergast, M., Li, L., Evans, E., & Hall, E. (2013). Consistency in Self-Reports of Drug Use Frequency by High-Risk Offenders Over a 5-Year Interval. The Prison Journal, 93(4), 375-389. 10.1177/0032885513500616
- Evans, E., Li, L., Grella, C., Brecht, M.-L., & Hser, Y.-I. (2013). Developmental timing of first drug treatment and 10-year patterns of drug use. Journal of Substance Abuse Treatment, 44(3), 271-279. 10.1016/j.jsat.2012.07.012
- Evans, E., Li, L., Pierce, J., & Hser, Y.-I. (2013). Explaining long-term outcomes among drug dependent mothers treated in women-only versus mixed-gender programs. Journal of Substance Abuse Treatment, 45(3), 293-301. 10.1016/j.jsat.2013.04.003
- Anglin, M. D., Nosyk, B., Jaffe, A., Urada, D., & Evans, E. (2013). Offender Diversion Into Substance Use Disorder Treatment: The Economic Impact of California’s Proposition 36. American Journal of Public Health, 103(6), 1096-1102. 10.2105/ajph.2012.301168
- Du, J., Lombardi, C., Evans, E., Jiang, H., Zhao, M., & Meng, Y.-Y. (2012). A mixed methods approach to identifying factors related to voluntary HIV testing among injection drug users in Shanghai, China. International Journal of Infectious Diseases, 16(7), e498-e503. 10.1016/j.ijid.2012.02.013
- Nosyk, B., Sun, H., Evans, E., Marsh, D. C., Anglin, M. D., Hser, Y.-I., & Anis, A. H. (2012). Defining dosing pattern characteristics of successful tapers following methadone maintenance treatment: results from a population-based retrospective cohort study. Addiction, 107(9), 1621-1629. 10.1111/j.1360-0443.2012.03870.x
- Evans, E., Jaffe, A., Urada, D., & Anglin, M. D. (2012). Differential Outcomes of Court-Supervised Substance Abuse Treatment Among California Parolees and Probationers. International Journal of Offender Therapy and Comparative Criminology, 56(4), 539-556. 10.1177/0306624x11404827
- Hser, Y., Du, J., Li, J., Zhao, M., Chang, Y. J., Peng, C. Y., & Evans, E. (2012). Hepatitis C among methadone maintenance treatment patients in Shanghai and Kunming, China. Journal of Public Health, 34(1), 24-31. 10.1093/pubmed/fdr098
- Hser, Y.-I., Hunt, S. A., Evans, E., Chang, Y.-J., & Messina, N. P. (2012). Hispanic parenting women in women-only versus mixed-gender drug treatment: A 10-year prospective study. Addictive Behaviors, 37(6), 729-735. 10.1016/j.addbeh.2012.02.009
- Evans, E., Pierce, J., Li, L., Rawson, R., & Hser, Y.-I. (2012). More Alike than Different: Health Needs, Services Utilization, and Outcomes of Asian American and Pacific Islander (AAPI) Populations Treated for Substance Use Disorders. Journal of Ethnicity in Substance Abuse, 11(4), 318-338. 10.1080/15332640.2012.735172
- Hser, Y.-I., Kagihara, J., Huang, D., Evans, E., & Messina, N. (2012). Mortality among substance-using mothers in California: a 10-year prospective study. Addiction, 107(1), 215-222. 10.1111/j.1360-0443.2011.03613.x
- Hser, Y.-I., Li, J., Jiang, H., Zhang, R., Du, J., Zhang, C., Zhang, B., Evans, E., Wu, F., Chang, Y.-J., Peng, C., Huang, D., Stitzer, M. L., Roll, J., & Zhao, M. (2011). Effects of a randomized contingency management intervention on opiate abstinence and retention in methadone maintenance treatment in China. Addiction, 106(10), 1801-1809. 10.1111/j.1360-0443.2011.03490.x
- Huang, D. Y., Evans, E., Hara, M., Weiss, R. E., & Hser, Y.-I. (2011). Employment trajectories: Exploring gender differences and impacts of drug use. Journal of Vocational Behavior, 79(1), 277-289. 10.1016/j.jvb.2010.12.001
- Evans, E., Huang, D., & Hser, Y.-I. (2011). High-Risk Offenders Participating in Court-Supervised Substance Abuse Treatment: Characteristics, Treatment Received, and Factors Associated with Recidivism. The Journal of Behavioral Health Services & Research, 38(4), 510-525. 10.1007/s11414-011-9241-3
- Hser, Y.-I., Evans, E., Huang, D., & Messina, N. (2011). Long-term outcomes among drug-dependent mothers treated in women-only versus mixed-gender programs. Journal of Substance Abuse Treatment, 41(2), 115-123. 10.1016/j.jsat.2011.02.004
- Evans, E., Anglin, M. D., Urada, D., & Yang, J. (2011). Promising practices for delivery of court-supervised substance abuse treatment: Perspectives from six high-performing California counties operating Proposition 36. Evaluation and Program Planning, 34(2), 124-134. 10.1016/j.evalprogplan.2010.09.001
- Li, L., Evans, E., & Hser, Y.-I. (2010). A Marginal Structural Modeling Approach to Assess the Cumulative Effect of Drug Treatment on Later Drug Use Abstinence. Journal of Drug Issues, 40(1), 221-240. 10.1177/002204261004000112
- Prendergast, M., Huang, D., Evans, E., & Hser, Y.-I. (2010). Are There Gender Differences in Arrest Trajectories among Adult Drug Abuse Treatment Participants?. Journal of Drug Issues, 40(1), 7-26. 10.1177/002204261004000102
- Evans, E., Hser, Y.-I., & Huang, D. (2010). Employment Services Utilization and Outcomes among Substance Abusing Offenders Participating in California’s Proposition 36 Drug Treatment Initiative. The Journal of Behavioral Health Services & Research, 37(4), 461-476. 10.1007/s11414-009-9185-z
- Evans, E., Grella, C. E., Murphy, D. A., & Hser, Y.-I. (2010). Using Administrative Data for Longitudinal Substance Abuse Research. The Journal of Behavioral Health Services & Research, 37(2), 252-271. 10.1007/s11414-008-9125-3
- Evans, E., Li, L., & Hser, Y.-I. (2009). Client and program factors associated with dropout from court mandated drug treatment. Evaluation and Program Planning, 32(3), 204-212. 10.1016/j.evalprogplan.2008.12.003
- Brecht, M.-L., Stein, J., Evans, E., Murphy, D. A., & Longshore, D. (2009). Predictors of Intention to Change HIV Sexual and Injection Risk Behaviors among Heterosexual Methamphetamine-Using Offenders in Drug Treatment: A Test of the AIDS Risk Reduction Model. The Journal of Behavioral Health Services & Research, 36(2), 247-266. 10.1007/s11414-007-9106-y
- Hser, Y.-I., Evans, E., Huang, D., Brecht, M.-L., & Li, L. (2008). Comparing the dynamic course of heroin, cocaine, and methamphetamine use over 10 years. Addictive Behaviors, 33(12), 1581-1589. 10.1016/j.addbeh.2008.07.024
- Hser, Y.-I., Huang, D., Brecht, M.-L., Li, L., & Evans, E. (2008). Contrasting Trajectories of Heroin, Cocaine, and Methamphetamine Use. Journal of Addictive Diseases, 27(3), 13-21. 10.1080/10550880802122554
- Hser, Y.-I., & Evans, E. (2008). Cross-system data linkage for treatment outcome evaluation: Lessons learned from the California Treatment Outcome Project. Evaluation and Program Planning, 31(2), 125-135. 10.1016/j.evalprogplan.2008.02.003
- Murphy, D. A., Brecht, M.-L., Herbeck, D., Evans, E., Huang, D., & Hser, Y.-I. (2008). Longitudinal HIV Risk Behavior Among the Drug Abuse Treatment Outcome Studies (DATOS) Adult Sample. Evaluation Review, 32(1), 83-112. 10.1177/0193841x07307411
- Brecht, M.-L., Huang, D., Evans, E., & Hser, Y.-I. (2008). Polydrug use and implications for longitudinal research: Ten-year trajectories for heroin, cocaine, and methamphetamine users. Drug and Alcohol Dependence, 96(3), 193-201. 10.1016/j.drugalcdep.2008.01.021
- Evans, E., Murphy, D. A., Grella, C. E., Mouttapa, M., & Hser, Y.-I. (2008). Regulatory Issues Encountered When Conducting Longitudinal Substance Abuse Research. Journal of Drug Issues, 38(4), 1003-1025. 10.1177/002204260803800404
- Evans, E., Li, L., & Hser, Y.-I. (2008). Treatment entry barriers among California's Proposition 36 offenders. Journal of Substance Abuse Treatment, 35(4), 410-418. 10.1016/j.jsat.2008.03.003
- Fosados, R., Evans, E., & Hser, Y.-I. (2007). Ethnic differences in utilization of drug treatment services and outcomes among Proposition 36 offenders in California. Journal of Substance Abuse Treatment, 33(4), 391-399. 10.1016/j.jsat.2007.02.005
- Hser, Y.-I., Teruya, C., Brown, A. H., Huang, D., Evans, E., & Anglin, M. D. (2007). Impact of California’s Proposition 36 on the Drug Treatment System: Treatment Capacity and Displacement. American Journal of Public Health, 97(1), 104-109. 10.2105/ajph.2005.069336
- Hser, Y.-I., Evans, E., Teruya, C., Huang, D., & Anglin, M. D. (2007). Predictors of short-term treatment outcomes among California's Proposition 36 participants. Evaluation and Program Planning, 30(2), 187-196. 10.1016/j.evalprogplan.2006.10.008
- Ettner, S. L., Huang, D., Evans, E., Rose Ash, D., Hardy, M., Jourabchi, M., & Hser, Y.-I. (2006). Benefit-Cost in the California Treatment Outcome Project: Does Substance Abuse Treatment "Pay for Itself"?. Health Services Research, 41(1), 192-213. 10.1111/j.1475-6773.2005.00466.x
- Evans, E. (2006). Erratum. Health Services Research, 41(2), 613-613. 10.1111/j.1475-6773.2006.00541.x
- Evans, E., Longshore, D., Prendergast, M., & Urada, D. (2006). Evaluation of the Substance Abuse and Crime Prevention Act: Client Characteristics, Treatment Completion and Re-Offending Three Years After Implementation. Journal of Psychoactive Drugs, 38(sup3), 357-367. 10.1080/02791072.2006.10400599
- Teruya, C., Hardy, M., Hser, Y.-I., & Evans, E. (2006). Implementation of a Statewide Outcome Monitoring System: Lessons Learned From Substance Abuse Treatment Provider Staff. Qualitative Health Research, 16(3), 337-352. 10.1177/1049732305279137
- Evans, E., Spear, S. E., Huang, Y.-C., & Hser, Y.-I. (2006). Outcomes of Drug and Alcohol Treatment Programs Among American Indians in California. American Journal of Public Health, 96(5), 889-896. 10.2105/ajph.2004.055871
- Hser, Y.-I., Grella, C., Evans, E., & Huang, Y.-C. (2006). Utilization and Outcomes of Mental Health Services Among Patients in Drug Treatment. Journal of Addictive Diseases, 25(1), 73-85. 10.1300/j069v25n01_10
- Grella, C. E., Hser, Y.-I., Teruya, C., & Evans, E. (2005). How Can Research-Based Findings Be Used to Improve Practice? Perspectives from Participants in a Statewide Outcomes Monitoring Study. Journal of Drug Issues, 35(3), 469-483. 10.1177/002204260503500303
- Hser, Y.-I., Evans, E., & Huang, Y.-C. (2005). Treatment outcomes among women and men methamphetamine abusers in California. Journal of Substance Abuse Treatment, 28(1), 77-85. 10.1016/j.jsat.2004.10.009
- Evans, E., & Longshore, D. (2004). Evaluation of the Substance Abuse and Crime Prevention Act: Treatment Clients and Program Types During the First Year of Implementation. Journal of Psychoactive Drugs, 36(sup2), 165-174. 10.1080/02791072.2004.10400052
- Evans, E., & Hser, Y.-I. (2004). Pilot-Testing a Statewide Outcome Monitoring System: Overview of the California Treatment Outcome Project (CALTOP). Journal of Psychoactive Drugs, 36(sup2), 109-114. 10.1080/02791072.2004.10400045
- Hser, Y.-I., Evans, E., Huang, D., & Anglin, D. M. (2004). Relationship Between Drug Treatment Services, Retention, and Outcomes. Psychiatric Services, 55(7), 767-774. 10.1176/appi.ps.55.7.767
- Hser, Y.-I., Teruya, C., Evans, E., Longshore, D., Grella, C., & Farabee, D. (2003). Treating Drug-Abusing Offenders. Evaluation Review, 27(5), 479-505. 10.1177/0193841x03255774
-
article
- Bailey, A., Taylor, B., Pollack, H. A., Schneider, J., & Evans, E. (2023). Gender identity, stimulant drug use, and criminal justice history on internalized stigma among a nationally representative sample of adults who misuse opioids. https://doi.org/10.1007/s00127-023-02500-5
-
chapter
- Evans, E., & Hser, Y.-I. (2019). The Natural History, Clinical Course, and Long-Term Recovery from Opioid Use Disorders. In Treating Opioid Addiction. (pp. 181-196). 10.1007/978-3-030-16257-3_9